Press & Media

Carbon Biosciences Announces New Appointments to Board of Directors and Scientific Advisory Board
Read
Insilico Medicine appoints Carol Satler, MD., PhD, as Vice President of Clinical Development to advance non-oncology programs
Read
Insilico Medicine Appoints Carol Satler as VP of Clinical Development to Advance Non-Oncology Programs
ReadResearch

Measuring Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Not on Active Treatment (MOTION): A Study of the Effects of Riociguat on Patient-Reported Outcomes and an Exploration of Telemetric Technology in PAH
Read






